Serum Protein Markers (Hp, GC, C3) in Patients with Colon Cancer

dc.contributor.author	Archimandritis, A	en
dc.contributor.author	Theodoropoulos, G	en
dc.contributor.author	Tryphonos, M	en
dc.contributor.author	Germenis, A	en
dc.contributor.author	Tjivras, M	en
dc.contributor.author	Kalos, A	en
dc.contributor.author	Fertakis, A	en
dc.date.accessioned	2014-06-06T06:42:26Z
dc.date.available	2014-06-06T06:42:26Z
dc.date.issued	1993	en
dc.identifier.uri	http://dx.doi.org/10.1159/000154117	en
dc.identifier.uri	http://62.217.125.90/xmlui/handle/123456789/629
dc.subject	Colon Cancer	en
dc.subject	Serum Protein	en
dc.title	Serum Protein Markers (Hp, GC, C3) in Patients with Colon Cancer	en
heal.type	journalArticle	en
heal.identifier.primary	10.1159/000154117	en
heal.publicationDate	1993	en
heal.abstract	The phenotypes and gene frequencies of three serum protein systems – Hp, GC and C3 – were studied in 184 consecutive patients from all over Greece with colon cancer. Healthy Greeks studied previously in our department served as controls. No significant differences were found between patients and controls concerning GC and C3. Significant differences were found in the Hp system;	en
heal.journalName	Human Heredity	en
dc.identifier.doi	10.1159/000154117	en